01- Be an active member of the Takeda’s access community and value chain that ensure patients have access to innovative treatments ensuring timely, sustainable reimbursement and uptake through robust payer value propositions, evidence generation, HTA readiness, and effective cross-functional delivery.
02- Work very closely with Global Access Strategy team to ensure execution within IBU.
03- Lead and own IBU access strategy, provide strategic inputs for 6 core markets, and execute market access readiness across international markets for Oveporexton.
04- Act as a core member of cross‑functional teams, working with global and IBU partners (Commercial, Medical Affairs, Regulatory, HEOR, Global Access & Pricing, Pipeline, etc.) to embed access considerations into key strategic decisions.
05- Be part of Global Pricing and Access (GPA) function, contributing to advance GPA governance and ways of working, to influencing functional excellence (Access, Pricing, cross‑TA collaboration, capability building) and to shaping the access vision and capability roadmap.
Requirements
↳- Solid experience in Local and preferably Regional Market Access & Pricing, with demonstrated leadership across TA areas and complex payer environments.
↳- Proven ability to shape TA‑level access strategy across the full asset lifecycle (launch, inline, LOE), including advisory to senior governance bodies.
↳- Deep knowledge of global payer systems, reimbursement pathways and pricing dynamics, particularly across Europe and Intercontinental markets.
↳- Strong portfolio readiness expertise, including payer scenario planning, pricing insights & trends, evidence requirements, and competitive access risk management.
↳- Advanced capability to integrate clinical, HEOR, RWE and competitive insights into clear payer value propositions and access decision‑making.
